Similar Researchers
Oana Danciu, MD
Translational Oncology Research Program
Professor
Division of Hematology and Oncology
College of Medicine
Email: ocdanciu@uic.edu
Oana Danciu, MD, is Associate Director of Clinical Research at the University of Illinois Cancer Center, a breast oncologist at UI Health and Professor in the Division of Hematology and Oncology at the University of Illinois College of Medicine at UIC. Her research is focused on breast cancer, early phase clinical trials development and experimental therapeutics. Her work has been presented at major national conferences, including the American Society of Clinical Oncology (ASCO) Breast Cancer Symposium, San Antonio Breast Cancer Symposium and ASCO Cancer Survivorship Symposium. Her extensive work includes developing a Phase I protocol with a new experimental agent, PAC-1 (first procaspase activating compound). PAC-1 is a small molecule that directly activates procaspase-3 and induces apoptosis of cancer cells. Additionally, she serves as Steering Committee Chair of the Big Ten Cancer Research Consortium (CRC). Her involvement in the Big Ten CRC Breast Cancer Working has led to collaborations outside UIC with nationally recognized breast oncologists. Her trial, “A Single Arm Phase II Study of Palbociclib in Combination with Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer,” was awarded by Pfizer as part of the ASPIRE program.
Education
- MD, Carol Davila University
Published Research
Other Link(s)
Research Focus
- Translational Oncology
- Breast
- Breast Cancer
- Clinical Trials
- Development
- Therapeutics